Healthkart – a health supplements startup – has closed a $153 million funding round led by ChrysCapital and Motilal Oswal Alternates, the company said in a statement, without disclosing further details. This also includes an Esop buyback of Rs 55 crore – the first-ever such exercise at the firm. Neo Group and Healthkart’s existing investor, A91 Partners , also participated in this round, the statement said.
Peak XV Partners – an early investor in Healthkart – has made an exit from the Gurgaon-based firm as part of the funding round, sources aware of the matter said. ET first reported on the impending deal at Healthkart with ChrysCapital in April. “We welcome ChrysCapital and Motilal Oswal to Healthkart and hope to leverage their expertise during the next phase of growth,” said Sameer Maheshwari, founder and CEO at Healthkart.
“Very excited about our first Esop buyback programme, which will create meaningful value for people who have played a critical role in building Healthkart.” Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories.
Technology
ChrysCapital, Motilal Oswal lead $153 million secondary funding in Healthkart at $500 million valuation
Health supplements startup Healthkart's existing investor, A91 Partners, and Neo Group also participated in the round. ET first reported on the impending deal at Healthkart with ChrysCapital in April.